This CBD Stock Is Set To Soar

Although many investors are focused on the production of cannabis that is high in tetrahydrocannabinol (THC), the cannabidiol (CBD) market is a multi-billion-dollar opportunity that is in the early innings of a major growth cycle.

Although CBD and THC are both derived from cannabis, the molecules could not be more different. THC is the primary psychoactive ingredient in marijuana that gets a user high. CBD does not have any psychoactive ingredients and does not get the user high.

Empower Clinics to Open Chicago Medical Cannabis and Wellness Clinic

Empower Clinics Inc. (CSE: EPW; FRA: 8EC), a leading owner and operator of medical cannabis and wellness clinics in the US, today announced that it has established a new clinic in downtown Chicago, as part of the company’s national expansion. This follows the late August signature of a statewide measure by Illinois’ governor to expand access to medical cannabis as an alternative for opioid painkillers.

3 Canadian CBD Leaders Investors Need to Know

Demand for products that contain cannabidiol (CBD) continues to increase and this is a trend that is expected to continue for years to come.

Although the CBD market is a multi-billion-dollar opportunity, we believe that this market is flying under the radar. When compared to companies focused on the production of cannabis that contains THC, companies focused on CBD tend to trade at a much lower valuation and we think this creates a unique opportunity for investors.

Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Zenabis

Isodiol International Inc. ( (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has signed a Letter of Intent (“LOI”) wit

5 Cannabis Stocks That Should Be On The Value Investors Radar

The cannabis sector was under significant pressure yesterday and investors are closely monitoring how these stocks trade from here.

Although this weakness is concerning, we have a favorable long-term outlook and expect cannabis stocks to rally off its recent lows. Over the last year, the legal cannabis industry has seen incredible growth and we are excited by this trend as well as the impact it will have on cannabis stocks.

MedReleaf Launches AltaVie, a Premium Cannabis Brand Designed with the Higher-End, Wellness-Focused Consumer in Mind

MedReleaf Corp. (TSX:LEAF) Canada's first and only ISO 9001 and ICH-GMP certified cannabis producer, today announced the introduction of AltaVie by MedReleaf, the Company's premium recreational cannabis brand designed for a premium consumer who is curious, discerning about life in general and searching for physical, mental and emotional enrichment.